Sandbox Financial Partners LLC Cuts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sandbox Financial Partners LLC decreased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 391 shares of the medical equipment provider’s stock after selling 44 shares during the period. Sandbox Financial Partners LLC’s holdings in Intuitive Surgical were worth $204,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of ISRG. Godsey & Gibb Inc. grew its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical in the 3rd quarter valued at about $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $36,000. Capital Performance Advisors LLP acquired a new stake in shares of Intuitive Surgical during the third quarter valued at about $38,000. Finally, DT Investment Partners LLC increased its position in shares of Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after acquiring an additional 36 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on ISRG shares. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. BTIG Research raised their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Robert W. Baird increased their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $554.17.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock worth $25,012,927 in the last ninety days. 0.80% of the stock is owned by insiders.

Intuitive Surgical Trading Up 1.5 %

Shares of NASDAQ ISRG opened at $592.64 on Friday. Intuitive Surgical, Inc. has a 12-month low of $362.14 and a 12-month high of $597.68. The company has a market cap of $211.09 billion, a price-to-earnings ratio of 95.28, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. The stock’s 50 day simple moving average is $540.66 and its 200 day simple moving average is $498.77.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.